Preliminary findings of an intervention integrating modified directly observed therapy and risk reduction counseling

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 19, Issue 4, 2007, Pages 561-564

  Mitchell, C G ^a   Freels, S ^a   Creticos, C M ^a   Oltean, A ^a   Douglas, R ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Heartland Health Outreach Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONDOM; COUNSELING; DATA ANALYSIS; FEASIBILITY STUDY; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK REDUCTION; SELF REPORT; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COUNSELING; DIRECTLY OBSERVED THERAPY; FEASIBILITY STUDIES; HIV INFECTIONS; HUMANS; PILOT PROJECTS; RISK REDUCTION BEHAVIOR; SEXUAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS;

EID: 34247093192     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120601040813     Document Type: Article

References (34)

1. Absalon, J., Della-Latta, P., Wu, F., & El-Sadr, W. (2005). Sexual barriers and condom use of HIV-infected men and women of color attending a treatment and care clinic. Journal of the National Medical Association, 97, S25-S31.
2. Altice, F.L., Mezger, J., Hodges, J., Bruce, R.D., Marinovich, A., Walton, M., et al. (2004). Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication. Clinical Infectious Diseases, 38, 376-388.
3. Avants, S.K., Warburton, L.A., Hawkins, K.A., & Margolin, A. (2000). Continuation of high-risk behavior by HIV-positive drug users: Treatment implications. Journal of Substance Abuse Treatment, 9, 15-22.
4. Bangsberg, D.R., Mundy, L.M., & Tulsky, J.P. (2001). Expanding directly observed therapy: Tuberculosis to human immunodeficiency virus. American Journal of Medicine, 110, 664-666.
5. Bingham, T., Johnson, D., & Harawa, N. (2001). Confidence in HAARTand recent unprotected anal sex among men who have sex with men. Paper presented at the 8th Conference on Retroviruses and Opportunistic Infections, Chicago, IL.
6. Carey, M.P., Maisto, S.A., Kalichman, S.C., Forsyth, A.D., Wright, E.M., & Johnson, B.T. (1997). Enhancing motivation to reduce the risk of HIV infection for economically disadvantaged urban women. Journal of Consulting and Clinical Psychology, 65, 531-541.
7. Carey, M.P., Carey, K.B., Maisto, S.A., Gleason, J.R., Gordon, C.M., & Brewer, K.K. (1999). HIV-risk behavior among outpatients at a state psychiatric hospital: Prevalence and risk modeling. Behavior Therapy, 30, 389-406.
8. Chaulk, C.P., Moore-Rice, K., Rizzo, R., & Chaisson, R.E. (1995). Eleven years of community-based directly observed therapy for tuberculosis. Journal of the American Medical Association, 274, 945-951.
9. Chen, S., Gibson, S., Katz, M.H., Klausner, J.D., Dilley, J.W., Schwarcz, S.K., et al. (2002). Continuing increases in sexual risk behavior and sexually transmitted diseases among men who have sex with men: San Francisco, CA, 1998-2002. American Journal of Public Health, 92, 1387-1388.
10. Chen, S., Gibson, S., Weide, D., & McFarland, W. (2003). Unprotected anal intercourse between potentially HIV-serodiscordant men who have sex with men, San Francisco. Journal of Acquired Immune Deficiency Syndromes, 33, 166-170.
11. Cohen, O.J., & Fauci, A.S. (1999). Transmission of drug-resistant strains of HIV-1: Unfortunate but inevitable. Lancet, 354, 697-698.
12. Conway, B., Prasad, J., Reynolds, R., Farley, J., Jones, M., Jutha, S., et al. (2004). Directly observed therapy for the management of HIV-infected patients in a methadone program. Clinical Infectious Diseases, 38, 402-409.
13. Fischl, M., Castro, J., Monroig, R., Scerpella, E., Thompson, L., Rechtine, D., et al. (2001). Impact of directly observed therapy on long-term outcomes in HIV clinical trials. Paper presented at the 8th Conference on Retroviruses and Opportunistic Infections, Chicago, IL.
14. Fisher, J.D., & Fisher, W.A. (1992). Changing AIDS risk behavior. Psychological Bulletin, 111, 455-474.
15. Friedland, G.H., & Williams, A. (1999). Attaining higher goals in HIV treatment: The central importance of adherence. AIDS, 13(Suppl. 1), S61-S72.
16. Gallant, J.E. (2005). Antiretroviral drug resistance and resistance testing. Topics in HIV Medicine, 13, 138-142.
17. Hecht, F.M., Colfax, G., Swannson M., & Chesney, M. (1998). Adherence and effectiveness of protease inhibitors in clinical practice. Paper presented at the 4th Annual Conference on Antiretrovirology. Chicago, IL.
18. Kushel, M.B., Hahn, J.A., Evans, J.L., Bangsberg, D.R., & Moss, A.R. (2005). Revolving doors: Imprisonment among the homeless and marginally housed population. American Journal of Public Health, 95, 1747-1752.
19. McGowan, J.P., Shah, S.S., Ganeal, C.E., Blum, S., Ernest J.A., Weidle, P.J., et al. (2001). HIV risk behavior among HIV-seropositive persons in the Bronx, NY. Paper presented at the 8th Conference on Retroviruses and Opportunistic Infections, Chicago, IL.
20. Meade, C.S., & Sikkema, K.J. (2005). HIV risk behavior among adults with severe mental illness: A systemic review. Clinical Psychology Reviews, 25, 433-457.
21. Mitty, J.A., Macalino, G.E., Bazerman, L.B., Loewenthal, H.G., Hogan, J.D., MacLeaod, C.J., et al. (2005). The use of community-based modified directly observed therapy for the treatment of HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes, 39, 545-550.
22. Pallela, F.J., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 26, 853-860.
23. Patterson, D., Swindells, S., Mohr, J., Brester, M., Verhis, E., Squier, C., Wagener, M., & Songh, N. (1999). How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMSCaps. Presented at the 3rd Conference on Retroviruses and Opportunistic Infections. Chicago, IL.
24. Perrin, L., & Telenti, A. (1998). HIV treatment failure: Testing for HIV resistance in clinical practice. Science, 280, 1871-1873.
25. Porco, T.C., Martin, J.N., Page-Shafer, K.A., Cheng, A., Charlebois, E., Grant, R.M., et al. (2004). Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS, 18, 81-88.
26. Prochaska, J.O., & DiClemente, C. (1984). The transtheoretical approach: Crossing traditional boundaries of therapy. Homewood, IL: Dow Jones-Irwin.
27. Rothman, J., & Sager, J.S. (1998). Case management: Integrating individual and community practice. Boston: Allyn & Bacon.
28. Royce, R.A., Sena, A., Cates, W., & Cohen, M.S. (1997). Sexual transmission of HIV. New England Journal of Medicine, 336, 1072-1078.
29. Sax, P.E., Islam, R., Walensky, R.P., Losina, E., Weinstein, M.C., Goldie, S.J., et al. (2005). Should resistance testing be performed for treatment-naïve HIV-infected patients? A cost effective analysis. Clinical Infectious Diseases, 41, 1316-1323.
30. Sollitto, S., Mehlman, M., Younger, S., & Lederman, M.M. (2001). Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment? AIDS, 15, 153-159.
31. Valleroy, L., Secura, G., MacKellar, D., & Behel, S., The Young Men's Survey Study Group, & Researchers from institutions in eight US cities (2001). High HIV and risk behavior prevalence among 23-29-year-old men who have sex with men in six US cities. Paper presented at the 8th Conference on Retroviruses and Opportunistic Infections, Chicago, IL.
32. Weiss, S.E. (1997). Universal directly observed therapy: A treatment strategy for tuberculosis. Clinics in Chest Medicine, 18, 155-163.
33. Williams, A. (1997). Antiretroviral therapy: Factors associated with adherence. Journal of the Association of Nurses in AIDS Care, 8, 18-31.
34. Woodside, M., & McClam, T. (2003). Generalist case management. Pacific Grove, CA: Brooks/Cole.